Chart calendar Novus Therapeutics, Inc.
Upcoming events on Novus Therapeutics, Inc.
Past events on Novus Therapeutics, Inc.
2024-07-10 02:30 pm | Annual General Meeting |
2024-06-03 02:30 pm | American Transplant Congress - Poster No: 6647 |
2024-06-03 09:15 am | American Transplant Congress - Poster No: 6647 |
2024-05-09 07:30 am | Q1 2024 Earnings Release |
2024-04-17 01:00 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
2024-03-28 04:01 pm | Q4 2023 Earnings Release |
2023-12-04 05:00 pm | Noble Capital Markets Emerging Growth Equity Conference |
2023-12-04 12:00 pm | Noble Capital Markets Emerging Growth Equity Conference |
2023-11-16 03:00 am | Jefferies London Healthcare Conference |
2023-11-09 04:01 pm | Q3 2023 Earnings Release |
2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster No - TH-PO835 |
2023-09-27 08:00 am | Cantor Global Healthcare Conference - Panel |
2023-08-10 07:00 am | Q2 2023 Earnings Release |
2023-06-21 02:30 pm | Annual General Meeting |
2023-06-09 09:00 am | Jefferies Global Healthcare Conference |
2023-05-11 04:30 pm | Q1 2023 Earnings Call |
2023-05-11 04:01 pm | Q1 2023 Earnings Release |
2023-04-01 05:00 am | International Society of Nephrology World Congress - Poster No - SAT-188 |
2023-03-31 05:00 am | International Society of Nephrology World Congress - Poster No - FRI-316 |
2023-03-30 04:30 pm | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | -12,9 -13,9 7.1% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -14,2 -15,3 7.29% | -18,5 -15,5 -19.26% | -36,9 -38,9 5.21% | -88,4 -41,4 -113.75% | -43,0 -44,9 4.28% | -49,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,0 -15,3 -4.65% | -23,2 -20,6 -12.51% | -36,9 -38,9 5.14% | -88,0 -41,3 -113.17% | -40,3 -42,8 5.78% | -48,0 |
Net income Million USD | Released Forecast Spread | -16,0 -15,3 -4.65% | -22,8 -20,5 -11.11% | -34,5 -39,0 11.49% | -88,0 -40,9 -115.02% | -40,3 -42,8 5.67% | -47,8 |
EPS USD | Released Forecast Spread | -24,5 -23,9 -2.26% | -15,7 -12,3 -27.75% | -2,33 -2,58 9.62% | -6,16 -2,75 -123.8% | -1,64 -1,77 7.43% | -1,30 |
Announcement Date | 17/03/20 | 30/03/21 | 24/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,86 -11,2 11.84% | -9,28 -11,3 17.99% | -10,6 -10,9 2.7% | -58,7 -11,5 -410.33% | -11,1 -11,0 -1% | -10,4 -11,4 9.05% | -11,2 -13,6 17.66% | -10,3 -12,2 15.03% | -10,9 -13,0 16.39% | -12,5 | -12,8 | -12,9 | -16,5 | -19,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,86 -11,2 11.53% | -9,25 -11,3 18.18% | -10,5 -10,9 3.71% | -58,4 -11,5 -408.79% | -10,8 -11,0 1.85% | -9,58 -11,4 15.73% | -10,3 -45,9 77.46% | -9,63 -12,0 19.78% | -10,3 -13,0 20.81% | -12,3 | -12,6 | -12,8 | -16,2 | -19,3 |
Net income Million USD | Released Forecast Spread | -9,86 -10,9 9.19% | -9,25 -11,1 16.7% | -10,5 -10,6 1.28% | -58,4 -11,2 -420.51% | -10,8 -10,7 -0.52% | -9,58 -11,4 15.61% | -10,3 -13,0 20.45% | -9,63 -12,0 19.62% | -10,3 -13,0 20.81% | -12,0 | -12,6 | -12,9 | -16,2 | -19,3 |
EPS USD | Released Forecast Spread | -0,69 -0,68 -1.85% | -0,65 -0,70 7.67% | -0,73 -0,68 -7.35% | -4,09 -0,70 -482.21% | -0,75 -0,64 -17.8% | -0,40 -0,46 12.66% | -0,35 -0,46 23.91% | -0,29 -0,39 26.27% | -0,34 -0,33 -3.03% | -0,32 | -0,32 | -0,33 | -0,37 | -0,44 |
Announcement Date | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | 13/05/24 | - | - | - | - | - |
Past sector events for Novus Therapeutics, Inc.
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-08 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-07 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-06 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
2024-06-06 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |